Dashe Township, Kaohsiung County, Taiwan

Shing-Mein Wu

This inventor holds 1 USPTO granted patent. Top assignee: Industrial Technology Research Institute. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shing-Mein Wu. Retrieved from https://idiyas.com/inventor/shing-mein-wu-eb67uh6m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shing-Mein Wu: Innovator in Neurodegenerative Research

Introduction

Shing-Mein Wu is a prominent inventor based in Dashe Township, Kaohsiung County, Taiwan. He has made significant contributions to the field of neurodegenerative research, particularly through his innovative work in transgenic mammals.

Latest Patents

Wu holds a patent for a neurodegenerative, non-human transgenic mammal expressing a TrkA fusion protein. This invention provides a valuable model for studying neurodegenerative diseases, as it includes a TrkA-hFc transgene that encodes at least a TrkA fusion protein. The implications of this research are profound, offering insights into potential therapeutic approaches for neurodegenerative conditions.

Career Highlights

Shing-Mein Wu is affiliated with the Industrial Technology Research Institute, where he has been instrumental in advancing research in biotechnology and genetic engineering. His work has not only contributed to scientific knowledge but also has potential applications in medical research and treatment.

Collaborations

Wu has collaborated with notable colleagues, including Yuan-Jang Tsai and Chrong-Shiong Hwang. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their respective fields.

Conclusion

Shing-Mein Wu's contributions to neurodegenerative research through his innovative patent and collaborative efforts highlight his role as a key figure in advancing scientific understanding and potential treatments for neurodegenerative diseases. His work continues to inspire future research in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…